Related Experiment Video

Updated: Sep 30, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated

Andrew Xiao1, Hua Wu, Pier Paolo Pandolfi

  • 1Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Cancer Cell
|June 28, 2002
PubMed

Insights

Researchers created a new mouse model for astrocytoma by inactivating key proteins in astrocytes. This model mimics human disease, showing accelerated tumor growth with PTEN mutations and offering insights into astrocytoma progression.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Genetics

Background:

  • The retinoblastoma protein (pRb) family, including pRb, p107, and p130, plays a crucial role in cell cycle regulation.
  • Dysregulation of these proteins is implicated in various cancers, including astrocytoma.
  • Understanding the specific roles of pRb family members in astrocyte biology is essential for developing effective cancer therapies.

Purpose of the Study:

  • To establish a preclinical model for high-grade astrocytoma using transgenic mice.
  • To investigate the role of pRb, p107, and p130 inactivation in astrocyte proliferation and tumor formation.
  • To explore the impact of PTEN and p53 mutations on astrocytoma development and progression.

Main Methods:

  • Transgenic expression of T(121) (truncated SV40 T antigen) under the GFAP promoter to inactivate pRb, p107, and p130 in astrocytes.
  • Utilizing a conditional allele of T(121) to circumvent early lethality and study adult astrocytoma development.
  • Analyzing astrocytoma development in PTEN(+/-) and p53(+/-) backgrounds to assess genetic modifiers.

Main Results:

  • Inactivation of pRb, p107, and p130 in astrocytes led to perinatal lethality with neural precursor expansion and anaplastic astrocyte populations.
  • Adult mice with conditional T(121) expression developed high-grade astrocytoma, characterized by aberrant proliferation and apoptosis.
  • Astrocytoma development was accelerated in a PTEN(+/-) background, with activated Akt observed in regions of decreased apoptosis.
  • p53(+/-) background did not significantly accelerate astrocytoma development.

Conclusions:

  • The developed transgenic mouse model is highly penetrant and accurately reflects key events in human astrocytoma.
  • PTEN mutation significantly accelerates astrocytoma progression, highlighting its critical role in the disease.
  • This model provides valuable insights into the molecular mechanisms underlying astrocytoma development and offers a platform for preclinical testing.

More Related Videos

Translational Orthotopic Models of Glioblastoma Multiforme07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...